1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow SYNB1934v1: new trials by email Literature Review of SYNB1934v1 trials Research Report on SYNB1934v1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3) SYNB1934v1, Placebo - Phenylketonuria | Phase 3 | Terminated | Synlogic | 35 | 2023-07-05 | 2024-06-20 |
Metabolism, Inborn Errors (1) · Phenylketonurias (1)
Synlogic (1)
Canada (1) · Georgia (1) · Turkey (Türkiye) (1) · United States (1)